Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The
DAPADream
study
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 23, Issue 2, Pages 599-608
Publisher
Wiley
Online
2020-11-21
DOI
10.1111/dom.14258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT ‐2 study): 52‐week results from a randomized controlled trial
- (2020) Chantal Mathieu et al. DIABETES OBESITY & METABOLISM
- Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
- (2019) Thomas Danne et al. DIABETES CARE
- International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated with Sodium-Glucose Cotransporter (SGLT) Inhibitors
- (2019) Thomas Danne et al. DIABETES CARE
- Comparison of pharmacokinetics and the exposure‐response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus
- (2019) D. Busse et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2
- (2019) Chantal Mathieu et al. DIABETES CARE
- Reduced burden of diabetes and improved quality of life: experiences from unrestricted day‐and‐night hybrid closed‐loop use in very young children with type 1 diabetes
- (2019) Gianluca Musolino et al. PEDIATRIC DIABETES
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery
- (2019) Klemen Dovc et al. DIABETES CARE
- Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial
- (2019) Klemen Dovc et al. DIABETES CARE
- Efficacy of the Diabeloop closed‐loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise
- (2019) Hélène Hanaire et al. DIABETES OBESITY & METABOLISM
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
- (2019) Sue A. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks
- (2019) Simeon I Taylor et al. Lancet Diabetes & Endocrinology
- Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting
- (2018) Gregory P. Forlenza et al. Diabetes Technology & Therapeutics
- Performance of Medtronic Hybrid Closed-Loop Iterations, Results from a Randomized Trial in Adolescents with Type 1 Diabetes
- (2018) Martin de Bock et al. Diabetes Technology & Therapeutics
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
- (2018) Julio Rosenstock et al. DIABETES CARE
- Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
- (2018) Martin Tauschmann et al. LANCET
- Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
- (2017) Alanna Weisman et al. Lancet Diabetes & Endocrinology
- Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp
- (2013) Moshe Phillip et al. NEW ENGLAND JOURNAL OF MEDICINE
- MD-Logic Artificial Pancreas System: A pilot study in adults with type 1 diabetes
- (2010) E. Atlas et al. DIABETES CARE
- Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas
- (2008) S. A. Weinzimer et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search